Skip to content

Study on probiotics assisting anti-tuberculosis therapy by regulating intestinal flora

Study on probiotics assisting anti-tuberculosis therapy by regulating intestinal flora

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075027
Enrollment
Unknown
Registered
2023-08-23
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Experimental group:Based on the regular use of medication according to the treatment plan, take probiotic freeze-dried powder twice a day, with one bag each time
Control group:Use medication according to the treatment plan and do not take any microbial preparations

Sponsors

Infectious Disease Hospital of Heilongjiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Positive patients who meet diagnostic criteria for tuberculosis.

Exclusion criteria

Exclusion criteria: 1.Under the age of 18, not permanently settled in Heilongjiang Province 2.Acute infection of the digestive system and urinary system occurred in the past 4 weeks 3.Have taken antibiotics or microbial preparations in the past 4 weeks 4.Those who have had major gastrointestinal surgery within 5 years 5.Patients with inflammatory bowel disease 6.Pregnant and lactating women 7.Patients with coronary heart disease, liver disease and kidney disease 8.People with shingles and HIV infection 9.Organ transplant recipients 10.History of malignancy within the last 5 years

Design outcomes

Primary

MeasureTime frame
IL-6;Fecal flora sequencing;

Secondary

MeasureTime frame
CD4 T cell;CD8 T cell;routine blood test;Liver Function;Kidney Function;Uric acid;Coagulation function;serum electrolytes;

Countries

China

Contacts

Public ContactLi Ting

Infectious Disease Hospital of Heilongjiang Province

18145149666@163.com+86 181 4514 9666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026